| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2002 | CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors |
| 12/11/2002 | CN1384743A Remedies or preventives for diseases in association with chemokines |
| 12/11/2002 | CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/11/2002 | CN1384741A Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 12/11/2002 | CN1384740A Delayed-action form of administration containing tramadol saccharinate |
| 12/11/2002 | CN1384739A Oral pharmaceutical forms of administration with a delayed action |
| 12/11/2002 | CN1384738A Transdermal drug delivery devices |
| 12/11/2002 | CN1384735A Oral dosage forms |
| 12/11/2002 | CN1384734A Surface modified particulate compositions of biologically active substances |
| 12/11/2002 | CN1384733A Dry powder compositions having improved dispersivity |
| 12/11/2002 | CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors |
| 12/11/2002 | CN1384104A Usage, kit and composition of pyrrole derivative |
| 12/11/2002 | CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative |
| 12/11/2002 | CN1384090A Extraction process of tanshin general phenolic acid and its prepn and use |
| 12/11/2002 | CN1383883A Chinese medicine for treating pharyngitis and globus hystericus and its prepn |
| 12/11/2002 | CN1383874A External medicine for treating mastopathy and its prepn |
| 12/11/2002 | CN1383869A Ointment for healing tranumatic injury fast |
| 12/11/2002 | CN1383865A Medicine for treating acute and chronic pharyngitis and its prepn |
| 12/11/2002 | CN1383849A Burn and scald treating oil |
| 12/11/2002 | CN1383832A Nano abalone shell and its prepn |
| 12/11/2002 | CN1383829A Compound folic acid prepn for preventing and treating homocysteinemia and relevant diseases |
| 12/11/2002 | CN1383828A Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 12/11/2002 | CN1383827A Prepn of antiviral N-9 substituted guanine medicine powder for injection |
| 12/11/2002 | CN1383826A Silkworm disease preventing and treating medicine and its prepn |
| 12/11/2002 | CN1383825A Flunarizine hydrochloride injection and its prepn process |
| 12/11/2002 | CN1383824A Nasal cavity administrated huperzine prepn |
| 12/11/2002 | CN1383823A Method of applying MEK inhibitor to treat or inhibit neutrophil chemotaxis |
| 12/11/2002 | CN1383822A Tefu medicine liquid and its prepn |
| 12/11/2002 | CN1383821A Veterinary injection containing albendazole sulfoxide or its salt |
| 12/11/2002 | CN1383820A Composite medicine for treating male's impotence and prospermia and its prepn process |
| 12/11/2002 | CN1383819A Protocyanidin slow release capsule |
| 12/11/2002 | CN1383818A Application of skullcap stem and leaf general flavone and wild baicalin in preparing dementia resisting medicine |
| 12/11/2002 | CN1383817A Oral Breviscapine slow release prepn |
| 12/11/2002 | CN1383816A External Tranilast lipid gel prepn and its prepn process |
| 12/11/2002 | CN1383815A Compound prepn of ornithine and asparagic acid for preventing and treating hepatosis and hepatic encephalopathy and its prepn process |
| 12/11/2002 | CN1383814A Oral quick disintegrating tablet and its prepn process |
| 12/11/2002 | CN1095847C New 17,20-epoxy derivatives of pregnane |
| 12/11/2002 | CN1095844C Alcohol derivative of Triperygium wilfordii lactone, its prep. and application |
| 12/11/2002 | CN1095841C 化合物 Compound |
| 12/11/2002 | CN1095839C 4,5-diaryl oxazole derivatives |
| 12/11/2002 | CN1095836C Benzimidazole derivative |
| 12/11/2002 | CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative |
| 12/11/2002 | CN1095834C Quinolinone derivatives and antianaphylactic agent containing said quinolinone derivative as biological active component |
| 12/11/2002 | CN1095828C Antitumor 2-aminocarbonyl-1-2-bis (methylsulfonyl)-1-(substd.) hydrazines |
| 12/11/2002 | CN1095677C 化合物 Compound |
| 12/11/2002 | CN1095676C Health food capable of lowering blood lipoid, resisting senility and regulating immunity |
| 12/11/2002 | CN1095669C Medicine composition for saponin containing protopanaxyndiol component and preparing process and application thereof |
| 12/11/2002 | CN1095668C Use of combination of progestational agent and nitric oxide synthetase substrate and/or donor in prep. of medicine for treatment of preeclampsia and preterm labor |
| 12/11/2002 | CN1095667C Novel compositions based on normegestrol derivatives and their production process |
| 12/11/2002 | CN1095666C Codeine containing formulation |
| 12/11/2002 | CN1095665C Modified-release metronidazole compositions and method for making and using same |
| 12/11/2002 | CN1095664C Thiadizoles compound and drug compositions and use thereof |
| 12/11/2002 | CN1095663C Method for inhibiting LDL oxidation and atherosclerosis |
| 12/11/2002 | CN1095662C Injection formulations of avermectins or milbemycins based on castor oil, prep. thereof and related use of castor oil |
| 12/11/2002 | CN1095661C Anti-inflammatory and analgesic therapeutic composition containing nimesulide for use transdermally and prepn. thereof |
| 12/11/2002 | CN1095660C Pyriquitone releasing agent and its preparation |
| 12/11/2002 | CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 12/11/2002 | CA2350936A1 Prevention of flight dvt |
| 12/10/2002 | US6493570 Administering a halogenated xanthene to a patient prior to imaging, a portion of said halogenated xanthene being retained in said diseased tissue; and imaging said patient using a detected signal from said halogenated xanthene |
| 12/10/2002 | US6492556 Form a of fluoxetine hydrochloride in pure form characterized by having an x-ray powder diffraction pattern consistent with fluoxetine hydrochloride, having a single endotherm as determined by differential scanning calorimetry |
| 12/10/2002 | US6492554 Selective androgen receptor modulators and methods of use thereof |
| 12/10/2002 | US6492552 Disulfide derivatives useful for treating allergic diseases |
| 12/10/2002 | US6492550 Alpha-substituted thio, -oxo trifluoromethylketones as phospholipase inhibitors |
| 12/10/2002 | US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 12/10/2002 | US6492531 Method of treating cognitive disorders |
| 12/10/2002 | US6492530 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| 12/10/2002 | US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 12/10/2002 | US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis. |
| 12/10/2002 | US6492496 Antibodies to the receptor protein designated 2F1 |
| 12/10/2002 | US6492434 Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives |
| 12/10/2002 | US6492429 Apocynin and an inhibitor of inducible nitric oxide synthase |
| 12/10/2002 | US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems |
| 12/10/2002 | US6492427 Methods for treating multiple sclerosis |
| 12/10/2002 | US6492426 Side effect reduction |
| 12/10/2002 | US6492425 Inhibitors of transcription factor-NF-κB |
| 12/10/2002 | US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 12/10/2002 | US6492423 Hepatitis c and b viricides |
| 12/10/2002 | US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 12/10/2002 | US6492419 Aqueous insecticidal pour-on formulation |
| 12/10/2002 | US6492418 Administering benzamide-disulfide derivative for therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lung and manifestations of systemic mastocytosis |
| 12/10/2002 | US6492417 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists |
| 12/10/2002 | US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/10/2002 | US6492415 Use of benzopyranols to treat neurological disorders |
| 12/10/2002 | US6492414 Retinoic acid receptor agonists for the inhibition of alveolar destruction and/or promoting formation of alveoli in lung tissue |
| 12/10/2002 | US6492413 For use in therapy of pain, arthritis, fever |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer |
| 12/10/2002 | US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders |
| 12/10/2002 | US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1 |
| 12/10/2002 | US6492407 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones |
| 12/10/2002 | US6492406 Pharmaceutically active compounds |
| 12/10/2002 | US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof |
| 12/10/2002 | US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability |
| 12/10/2002 | US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage |
| 12/10/2002 | US6492399 Pharmaceutical compositions and methods for use |
| 12/10/2002 | US6492396 Substituted thioacetamides |
| 12/10/2002 | US6492395 Topical formulation of alkyl-, phenyl-pyridone |
| 12/10/2002 | US6492393 Compounds useful as anti-inflammatory agents |
| 12/10/2002 | US6492391 Treating bacterial infection |
| 12/10/2002 | US6492390 Treating cyclooxygenase-2 mediated disorders. |